ArticleReports of biochemistry & molecular biology2024
Effect of Active Compounds of Eruca Sativa Plant Extract on
Article in Reports of biochemistry & molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medicinal plants play an important role in agricultural production due to their therapeutic significance, particularly in the treatment of various pathological conditions. Methods: Active compounds in Eruca sativa were identified using High-Performance Liquid Chromatography (HPLC). Fifty isolates of Results: The highest percentage of S. aureus was found in wound samples, with 22 isolates (44%). The isolates showed variability in their ability to form biofilms. The efficacy test revealed that plants treated with different concentrations of brassinolide (0, 1.5, 2.5, 3.5 mg/L) and Eruca sativa showed inhibition of S. aureus growth in isolates (S2, S7, S10, S15, S16, S31, S42, S48, S50) with alcohol concentrations (5, 25, 75 mg/ml). The effect of Eruca sativa plant extract was dependent on the concentration of brassinolide applied. The highest inhibition was observed with brassinolide concentration of 3.5 mg/L-1 and alcohol extract concentrations of 50 and 75 mg/ml. Conclusions: The alcoholic extract from the leaves of Eruca sativa, combined with brassinolide, proved effective in inhibiting the growth and biofilm formation of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.